Analyst Rating Update on Imprivata (IMPR)

Imprivata (IMPR) : Zacks Investment Research ranks Imprivata (IMPR) as 3, which is a Hold recommendation. A total of 6 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 6 research analysts is 3, which indicates as a Hold.

Company shares have received an average consensus rating of Hold for the current week


Imprivata (NYSE:IMPR): The stock was completely flat for the day, closing at $19.11 on Wednesday. The flat closing masks the intraday volatility in the stock. After opening at $19.10, the stock touched an intraday high of $19.12 and a low of $19.09. Neither the bulls nor the bears asserted their supremacy at close, due to which the stock closed completely flat. The stock previously closed at $19.11. The total trading volume on Wednesday was 1,369,145.

Imprivata, Inc. is a provider of healthcare information technology) IT security solutions. The Companys solutions provide authentication management, access to patient information and communications technologies to the healthcare industry. Its solutions include Imprivata OneSign, Imprivata Cortext and Imprivata Confirm ID. Imprivata OneSign is a suite of authentication and access management products, which consists of three offerings: authentication management, enterprise single sign-on and workflow automation. Imprivata Cortext is a cloud-supported communications platform that provides healthcare organizations with texting and messaging services. Imprivata Confirm ID is a software product for electronic prescribing of controlled substances (EPCS).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *